Atezolizumab: feasible second-line therapy for patients with non-small cell lung cancer? A review of efficacy, safety and place in therapy

by Fanny Jean, Pascale Tomasini, Fabrice Barlesi
Published 2017-12-01

Bevacizumab in the treatment of nonsquamous non-small cell lung cancer: clinical trial evidence and experience

by Laurent Greillier, Pascale Tomasini, Fabrice Barlesi
Published 2016-10-01

Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomes

by Pascale Tomasini, Fabrice Barlesi, Celine Mascaux, Laurent Greillier
Published 2016-05-01

Ipilimumab: its potential in non-small cell lung cancer

by Pascale Tomasini, Nataliya Khobta, Laurent Greillier, Fabrice Barlesi
Published 2012-03-01

Personalised medicine for nonsmall cell lung cancer

by Céline Mascaux, Pascale Tomasini, Laurent Greillier, Fabrice Barlesi
Published 2017-11-01

Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastases

by Pascale Tomasini, Julie Egea, Maxime Souquet-Bressand, Laurent Greillier, Fabrice Barlesi
Published 2019-02-01

Solitary cystic mediastinal lymphangioma

by Philippe Astoul, Pascal Chanez, Fabien Maldonado, Delphine Trousse, Pascale Tomasini, Nataliya Khobta
Published 2013-03-01

Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?

by Arnaud Boyer, Eddy Pasquier, Pascale Tomasini, Joseph Ciccolini, Laurent Greillier, Nicolas Andre, Fabrice Barlesi, Celine Mascaux
Published 2018-03-01

Anaphylactic Reaction to Pemetrexed: A Case Report

by Heloise Capelle, Joelle Birnbaum, Pascale Tomasini, Céline Tummino, Marion Gouitaa, Nathalie Ausias, Denis Charpin, Fabrice Barlesi, Marc Montana
Published 2014-05-01

EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer

by Pascale Tomasini, Cindy Serdjebi, Nataliya Khobta, Philippe Metellus, L’Houcine Ouafik, Isabelle Nanni, Laurent Greillier, Anderson Loundou, Frederic Fina, Celine Mascaux, Fabrice Barlesi
Published 2016-12-01

Low lamin A expression in lung adenocarcinoma cells from pleural effusions is a pejorative factor associated with high number of metastatic sites and poor Performance status.

by Elise Kaspi, Diane Frankel, Julien Guinde, Sophie Perrin, Sophie Laroumagne, Andrée Robaglia-Schlupp, Kevin Ostacolo, Karim Harhouri, Rachid Tazi-Mezalek, Joelle Micallef, Hervé Dutau, Pascale Tomasini, Annachiara De Sandre-Giovannoli, Nicolas Lévy, Pierre Cau, Philippe Astoul, Patrice Roll
Published 2017-01-01